Credit: TanyaJoy / iStock / Getty Images Plus Missense variants remain a challenge in genetic interpretation due to their subtle and context-dependent effects. While current prediction models perform well in…
Credit: Jutta Klee / Getty Images Founded by Flagship Pioneering in 2019, Cellarity seeks to embrace biology’s complexity, as diseases are often not driven by a single target, but emerge…
Credit: Jackie Niam / iStock / Getty Images Plus Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed…
Nasal vaccines show new promise for human papillomavirus (HPV) to address cervical cancer and whooping cough. In business news, Korro’s stock craters 81% as AATD interim Phase I/II results miss…
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, then dropped on Thursday,…
uniQure’s “game changing” data announced in September, which showed significant slowing of Huntington’s disease (HD) progression in patients treated with its gene therapy candidate AMT-130, may not be enough to…
AI-generated antibodies by RFdiffusion The antibody drug market value is expected to reach $445 billion in the next five years, with over 160 antibodies currently licensed globally for a wide…
Drug discovery has not yet had its “ChatGPT moment,” according to Arman Zaribafiyan, PhD, head of product, AI simulation and platforms, at SandboxAQ, in an interview with GEN. “We can’t…
In industrial engineering, digital twins—computer models of systems or processes—let scientists try out ideas before finalizing designs. In addition, on the factory floor, twins can model processes in real-time, enabling…
Artistic depiction of the virtual cell At NVIDIA GTC in Washington DC, Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to drive the development and adoption of virtual…